SCHEMBL1088519

SCHEMBL1088519

CN1CCCC1CCNc1nc(N2CCCCCCC2)c2ccccc2n1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 1/20 0.58
HRH1 P35367 1/20 0.58
HRH3 Q9Y5N1 1/20 0.58
MRGPRX1 Q96LB2 1/20 0.55
ACP1 P24666 3/20 0.52
KMT2A Q03164 4/20 0.48
MEN1 O00255 3/20 0.48
LMNA P02545 3/20 0.48
MAPT P10636 3/20 0.48
HPGD P15428 2/20 0.48
HTT P42858 2/20 0.48
NPSR1 Q6W5P4 2/20 0.48
RECQL P46063 2/20 0.48
ALDH1A1 P00352 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP2D6 P10635 1/20 0.48
CYP2C9 P11712 1/20 0.48
ALOX12 P18054 1/20 0.48
CYP2C19 P33261 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090440 1.00 HRH2 (0.58) HRH2HRH1HRH3MRGPRX1ACP1
SCHEMBL1089426 1.00 HRH2 (0.58) HRH2HRH1HRH3MRGPRX1ACP1
SCHEMBL1090557 0.99 HRH2 (0.57) HRH2HRH1HRH3MRGPRX1ACP1
SCHEMBL1089544 0.92 HRH2 (0.56) HRH2HRH1HRH3MRGPRX1ACP1
SCHEMBL1089408 0.89 MRGPRX1 (0.52) HRH2HRH1HRH3MRGPRX1ACP1
SCHEMBL1090499 0.88 MRGPRX1 (0.53) HRH2HRH1HRH3MRGPRX1ACP1
SCHEMBL1090562 0.86 HRH2 (0.53) HRH2HRH1HRH3MRGPRX1ACP1
SCHEMBL1089099 0.81 KAT2B (0.49) HRH2HRH1HRH3MRGPRX1ACP1
SCHEMBL1089901 0.79 MRGPRX1 (0.64) HRH3MRGPRX1ACP1KMT2AMEN1
SCHEMBL1089359 0.79 MRGPRX1 (0.64) HRH3MRGPRX1ACP1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 HRH2 261/4885HRH1 155/4885HRH3 94/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 HRH2 261/4885HRH1 155/4885HRH3 94/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 HRH2 261/4885HRH1 155/4885HRH3 94/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.